Polonezii de la Polpharma preiau compania românească Biofarm, printr-o tranzacție estimată la peste un sfert de miliard de euro

Biofarm, a leading Romanian pharmaceutical company, joins the Polpharma Group, enhancing its market position and resources for future development. This strategic move aims to improve patient access to medications in Romania and supports Biofarm's growth through Polpharma's expertise. The transaction, valued at approximately 257 million euros, reflects Polpharma's commitment to the Romanian market and aims to integrate Biofarm while maintaining its local identity. Key executives from Polpharma will join Biofarm's board to ensure a smooth transition and collaboration.